{
    "organizations": [],
    "uuid": "c856c42e96daa455b2727f9dd7ce4943e8f8ed83",
    "author": "",
    "url": "https://www.reuters.com/article/brief-progenics-pharmaceuticals-announce/brief-progenics-pharmaceuticals-announcesq1-loss-per-share-0-19-idUSASC0A0XQ",
    "ord_in_thread": 0,
    "title": "BRIEF-Progenics Pharmaceuticals Announces Q1 Loss Per Share $0.19",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9, 2018 / 11:36 AM / in 7 minutes BRIEF-Progenics Pharmaceuticals Announces Q1 Loss Per Share $0.19 Reuters Staff\nMay 9 (Reuters) - Progenics Pharmaceuticals Inc:\n* PROGENICS PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND BUSINESS UPDATE * Q1 LOSS PER SHARE $0.19\n* Q1 EARNINGS PER SHARE VIEW $-0.21 â€” THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)",
    "published": "2018-05-09T14:36:00.000+03:00",
    "crawled": "2018-05-09T14:50:56.048+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "minute",
        "pharmaceutical",
        "announces",
        "q1",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "may",
        "reuters",
        "progenics",
        "pharmaceutical",
        "inc",
        "progenics",
        "pharmaceutical",
        "announces",
        "first",
        "quarter",
        "financial",
        "result",
        "business",
        "update",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}